Last reviewed · How we verify
AlloStim-7
At a glance
| Generic name | AlloStim-7 |
|---|---|
| Also known as | Priming Phase, In-Situ Vaccine Phase |
| Sponsor | Mirror Biologics, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |